EICHOR
● Recruiting
Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy
Condition: Advanced NSCLC · Sponsor: Shanghai Junshi Bioscience Co., Ltd.
About this study
This is a multiple-arm, open phase II clinical trial evaluating the safety, tolerability,and preliminary efficacy of JS207 in NSCLC after progression following Platinum-based chemotherapy and immunotherapy.
This description comes directly from the study's public registry record.
Talk to the study team
Xiaojun Wang, Master · 021-50796193 · xiaojun_wang@junshipharma.com
Always discuss trial participation with your own doctor first.
Locations (18)
| Beijing Chest Hospital, Capital Medical University | Beijing, Beijing Municipality, China | Recruiting |
| Jilin Cancer Hospital | Jilin City, Changchun, China | Recruiting |
| Hunan Cancer Hospital | Hunan, Changsha, China | Recruiting |
| West China Hospital, Sichuan University | Sichuan, Chengdu, China | Recruiting |
| Second Affiliated Hospital, PLA Academy of Military Medical Sciences | Chongqing, Chongqing Municipality, China | Recruiting |
| Army Medical Center, PLA | Chongqing, Chongqing Municipality, China | Recruiting |
| The First Affiliated Hospital of Guangzhou Medical University | Guangdong, Guangzhou, China | Recruiting |
| Harbin Medical University Cancer Hospital | Heilongjiang, Harbin, China | Recruiting |
| Anyang Tumor Hospital | Anyang, Henan, China | Recruiting |
| The First Affiliated Hospital of Henan University of Science and Technology | Luoyang, Henan, China | Recruiting |
| The First Affiliated Hospital of Xinxiang Medical University | Xinxiang, Henan, China | Recruiting |
| The First People's Hospital of Changde | Changde, Hunan, China | Recruiting |
+ 6 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06924606